Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A novel 384-multiwell microelectrode array for the impedimetric monitoring of Tau protein induced neurodegenerative processes.

Jahnke HG, Krinke D, Seidel D, Lilienthal K, Schmidt S, Azendorf R, Fischer M, Mack T, Striggow F, Althaus H, Schober A, Robitzki AA.

Biosens Bioelectron. 2017 Feb 15;88:78-84. doi: 10.1016/j.bios.2016.07.074. Epub 2016 Jul 25.

PMID:
27506337
2.

Selective activators of protein phosphatase 5 target the auto-inhibitory mechanism.

Haslbeck V, Drazic A, Eckl JM, Alte F, Helmuth M, Popowicz G, Schmidt W, Braun F, Weiwad M, Fischer G, Gemmecker G, Sattler M, Striggow F, Groll M, Richter K.

Biosci Rep. 2015 Apr 20;35(3). pii: e00210. doi: 10.1042/BSR20150042.

3.

6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.

Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN.

J Neural Transm (Vienna). 2014 Oct;121(10):1245-57. doi: 10.1007/s00702-014-1185-3. Epub 2014 Mar 14.

PMID:
24627045
4.

Induced tauopathy in a novel 3D-culture model mediates neurodegenerative processes: a real-time study on biochips.

Seidel D, Krinke D, Jahnke HG, Hirche A, Kloß D, Mack TG, Striggow F, Robitzki A.

PLoS One. 2012;7(11):e49150. doi: 10.1371/journal.pone.0049150. Epub 2012 Nov 7.

5.

Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.

Schmidt W, Schäfer F, Striggow V, Fröhlich K, Striggow F.

Neuroscience. 2012 Dec 27;227:313-26. doi: 10.1016/j.neuroscience.2012.09.080. Epub 2012 Oct 13.

PMID:
23069763
6.

Oxygen glucose deprivation causes mitochondrial dysfunction in cultivated rat hippocampal slices: protective effects of CsA, its immunosuppressive congener [D-Ser](8)CsA, the novel non-immunosuppressive cyclosporin derivative Cs9, and the NMDA receptor antagonist MK 801.

Trumbeckaite S, Gizatullina Z, Arandarcikaite O, Röhnert P, Vielhaber S, Malesevic M, Fischer G, Seppet E, Striggow F, Gellerich FN.

Mitochondrion. 2013 Sep;13(5):539-47. doi: 10.1016/j.mito.2012.07.110. Epub 2012 Jul 21.

PMID:
22824458
7.

Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial.

Firsching R, Piek J, Skalej M, Rohde V, Schmidt U, Striggow F; KN38-7271 Study Group.

J Neurol Surg A Cent Eur Neurosurg. 2012 Aug;73(4):204-16. Epub 2012 Jun 13.

PMID:
22696266
8.

Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia.

Röhnert P, Schmidt W, Emmerlich P, Goihl A, Wrenger S, Bank U, Nordhoff K, Täger M, Ansorge S, Reinhold D, Striggow F.

J Neuroinflammation. 2012 Feb 28;9:44. doi: 10.1186/1742-2094-9-44.

9.

Cytosolic Ca2+ regulates the energization of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle.

Gellerich FN, Gizatullina Z, Trumbekaite S, Korzeniewski B, Gaynutdinov T, Seppet E, Vielhaber S, Heinze HJ, Striggow F.

Biochem J. 2012 May 1;443(3):747-55. doi: 10.1042/BJ20110765.

PMID:
22295911
10.

Impedance spectroscopy based measurement system for quantitative and label-free real-time monitoring of tauopathy in hippocampal slice cultures.

Jahnke HG, Braesigk A, Mack TG, Pönick S, Striggow F, Robitzki AA.

Biosens Bioelectron. 2012 Feb 15;32(1):250-8. doi: 10.1016/j.bios.2011.12.026. Epub 2011 Dec 23.

PMID:
22221799
11.

Insufficient endogenous redox buffer capacity may underlie neuronal vulnerability to cerebral ischemia and reperfusion.

Röhnert P, Schröder UH, Ziabreva I, Täger M, Reymann KG, Striggow F.

J Neurosci Res. 2012 Jan;90(1):193-202. doi: 10.1002/jnr.22754. Epub 2011 Oct 4.

PMID:
21971686
12.

Effects of cyclosporine A and its immunosuppressive or non-immunosuppressive derivatives [D-Ser]8-CsA and Cs9 on mitochondria from different brain regions.

Gizatullina ZZ, Gaynutdinov TM, Svoboda H, Jerzembek D, Knabe A, Vielhaber S, Malesevic M, Heinze HJ, Fischer G, Striggow F, Gellerich FN.

Mitochondrion. 2011 May;11(3):421-9. doi: 10.1016/j.mito.2010.12.012. Epub 2010 Dec 16.

PMID:
21167961
13.

A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring.

Krinke D, Jahnke HG, Mack TG, Hirche A, Striggow F, Robitzki AA.

Biosens Bioelectron. 2010 Sep 15;26(1):162-8. doi: 10.1016/j.bios.2010.06.002. Epub 2010 Jun 9.

PMID:
20591644
14.

The regulation of OXPHOS by extramitochondrial calcium.

Gellerich FN, Gizatullina Z, Trumbeckaite S, Nguyen HP, Pallas T, Arandarcikaite O, Vielhaber S, Seppet E, Striggow F.

Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1018-27. doi: 10.1016/j.bbabio.2010.02.005. Epub 2010 Feb 6. Review.

15.

Extramitochondrial Ca2+ in the nanomolar range regulates glutamate-dependent oxidative phosphorylation on demand.

Gellerich FN, Gizatullina Z, Arandarcikaite O, Jerzembek D, Vielhaber S, Seppet E, Striggow F.

PLoS One. 2009 Dec 9;4(12):e8181. doi: 10.1371/journal.pone.0008181.

16.

Mitochondria and energetic depression in cell pathophysiology.

Seppet E, Gruno M, Peetsalu A, Gizatullina Z, Nguyen HP, Vielhaber S, Wussling MH, Trumbeckaite S, Arandarcikaite O, Jerzembeck D, Sonnabend M, Jegorov K, Zierz S, Striggow F, Gellerich FN.

Int J Mol Sci. 2009 May 19;10(5):2252-303. doi: 10.3390/ijms10052252. Review.

17.

An impedimetric microelectrode-based array sensor for label-free detection of tau hyperphosphorylation in human cells.

Jahnke HG, Rothermel A, Sternberger I, Mack TG, Kurz RG, Pänke O, Striggow F, Robitzki AA.

Lab Chip. 2009 May 21;9(10):1422-8. doi: 10.1039/b819754g. Epub 2009 Feb 25.

PMID:
19417909
18.

Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats.

Gellerich FN, Gizatullina Z, Nguyen HP, Trumbeckaite S, Vielhaber S, Seppet E, Zierz S, Landwehrmeyer B, Riess O, von Hörsten S, Striggow F.

J Biol Chem. 2008 Nov 7;283(45):30715-24. doi: 10.1074/jbc.M709555200. Epub 2008 Jul 7.

19.

Tau kinase inhibitors protect hippocampal synapses despite of insoluble tau accumulation.

Hinners I, Hill A, Otto U, Michalsky A, Mack TG, Striggow F.

Mol Cell Neurosci. 2008 Mar;37(3):559-67. doi: 10.1016/j.mcn.2007.12.004. Epub 2007 Dec 15.

PMID:
18201898
20.

The specific FKBP38 inhibitor N-(N',N'-dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia.

Edlich F, Weiwad M, Wildemann D, Jarczowski F, Kilka S, Moutty MC, Jahreis G, Lücke C, Schmidt W, Striggow F, Fischer G.

J Biol Chem. 2006 May 26;281(21):14961-70. Epub 2006 Mar 17.

21.

Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice.

Gizatullina ZZ, Lindenberg KS, Harjes P, Chen Y, Kosinski CM, Landwehrmeyer BG, Ludolph AC, Striggow F, Zierz S, Gellerich FN.

Ann Neurol. 2006 Feb;59(2):407-11.

PMID:
16437579
22.

Preconditioning with thrombin can be protective or worsen damage after endothelin-1-induced focal ischemia in rats.

Henrich-Noack P, Striggow F, Reiser G, Reymann KG.

J Neurosci Res. 2006 Feb 15;83(3):469-75.

PMID:
16397902
23.

Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation.

Bukowska A, Lendeckel U, Hirte D, Wolke C, Striggow F, Röhnert P, Huth C, Klein HU, Goette A.

Cell Mol Life Sci. 2006 Feb;63(3):333-42.

PMID:
16389460
24.

Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures.

Martínez-Sánchez M, Striggow F, Schröder UH, Kahlert S, Reymann KG, Reiser G.

Neuroscience. 2004;128(4):729-40.

PMID:
15464281
25.
26.

Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors.

Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann KG.

Neurosci Lett. 2002 Aug 30;329(2):181-4.

PMID:
12165407
27.

Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia.

Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, Krug M, Reymann KG, Reiser G.

Eur J Neurosci. 2001 Aug;14(4):595-608.

PMID:
11556885
28.

Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria.

Schild L, Keilhoff G, Augustin W, Reiser G, Striggow F.

FASEB J. 2001 Mar;15(3):565-7. Epub 2001 Jan 19.

PMID:
11259368
29.

The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations.

Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, Reiser G.

Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2264-9.

30.

Regulation of intracellular calcium release channel function by arachidonic acid and leukotriene B4.

Striggow F, Ehrlich BE.

Biochem Biophys Res Commun. 1997 Aug 18;237(2):413-8.

PMID:
9268725
31.
32.

Ligand-gated calcium channels inside and out.

Striggow F, Ehrlich BE.

Curr Opin Cell Biol. 1996 Aug;8(4):490-5. Review.

PMID:
8791458
33.

Phorbol ester-induced shedding of intercellular adhesion molecule-1 (ICAM-1) on erythroleukemic K 562 cells.

Fritz S, Striggow F, Reinhold D, Schlüter T, Schönfeld P, Ansorge S, Bohnensack R.

Biochim Biophys Acta. 1996 Jul 24;1312(3):255-61.

34.
35.

Functional characterization of mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers.

Kunz WS, Kuznetsov AV, Schulze W, Eichhorn K, Schild L, Striggow F, Bohnensack R, Neuhof S, Grasshoff H, Neumann HW, Gellerich FN.

Biochim Biophys Acta. 1993 Aug 16;1144(1):46-53.

PMID:
8347661

Supplemental Content

Loading ...
Support Center